American Journal of Kidney Diseases
Volume 55, Issue 3 , Pages 580-589 , March 2010

Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis

  • Jula K. Inrig, MD, MHS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jula K. Inrig, MD, MHS, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8523

Received 7 April 2009 ,Accepted 14 August 2009.

References 

  1. Levin NW. Intradialytic hypertension: I. Semin Dial. 1993;6:370–371
  2. Fellner SK. Intradialytic hypertension: II. Semin Dial. 1993;6:371–373
  3. Chen J, Gul A, Sarnak MJ. Management of intradialytic hypertension: the ongoing challenge. Semin Dial. 2006;19:141–145
  4. Inrig JK, Oddone EZ, Hasselblad V, et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int. 2007;71:454–461
  5. Inrig JK, Patel UD, Toto RD, Szczech LA. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis. 2009;54:881–890
  6. Chou KJ, Lee PT, Chen CL, et al. Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int. 2006;69:1833–1838
  7. Raj DS, Vincent B, Simpson K, et al. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int. 2002;61:697–704
  8. Amerling RCG, Dubrow A, Levin NW, Osheroff R. Complications During Hemodialysis. Stamford, CT: Appleton & Lange; 1995;
  9. Cirit M, Akcicek F, Terzioglu E, et al. Paradoxical rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant. 1995;10:1417–1420
  10. Mees D. Rise in blood pressure during hemodialysis-ultrafiltration: a “paradoxical” phenomenon?. Int J Artif Organs. 1996;19:569–570
  11. Sarkar SR, Kaitwatcharachai C, Levin NW. Complications During Hemodialysis. New York: McGraw-Hill Professional; 2005;
  12. Reddan DN, Szczech LA, Hasselblad V, et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol. 2005;16:2162–2169
  13. Inrig JK, Patel UD, Gillespie BS, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis. 2007;50:108–118118.e1-4
  14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2005;43(suppl 1):S1–S290
  15. Stidley CA, Hunt WC, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol. 2006;17:513–520
  16. Li Z, Lacson E, Lowrie EG, et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis. 2006;48:606–615
  17. Zager PG, Nikolic J, Brown RH, et al. U Curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561–569
  18. Rahman M, Griffin V, Kumar A, Manzoor F, Wright JT, Smith MC. A comparison of standardized versus “usual” blood pressure measurements in hemodialysis patients. Am J Kidney Dis. 2002;39:1226–1230
  19. Agarwal R, Peixoto AJ, Santos SFF, Zoccali C. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2006;1:389–398
  20. Mendes RB, Santos SF, Dorigo D, et al. The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in haemodialysis patients. Blood Press Monit. 2003;8:243–248
  21. Gunal AI, Karaca I, Celiker H, Ilkay E, Duman S. Paradoxical rise in blood pressure during ultrafiltration is caused by increased cardiac output. J Nephrol. 2002;15:42–47
  22. Boon D, van Montfrans GA, Koopman MG, Krediet RT, Bos WJ. Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract. 2004;96:c82–c87
  23. Chaignon M, Chen WT, Tarazi RC, Nakamoto S, Bravo EL. Blood pressure response to hemodialysis. Hypertension. 1981;3:333–339
  24. Converse RL, Jacobsen TN, Toto RD, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912–1918
  25. Park J, Campese VM, Nobakht N, Middlekauff HR. Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J Appl Physiol. 2008;105:1873–1876
  26. Bazzato G, Coli U, Landini S, et al. Prevention of intra- and postdialytic hypertensive crises by captopril. Contrib Nephrol. 1984;41:292–298
  27. Erkan E, Devarajan P, Kaskel F. Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis. 2002;40:76–81
  28. El-Shafey EM, El-Nagar GF, Selim MF, El-Sorogy HA, Sabry AA. Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?. Clin Exp Nephrol. 2008;12:370–375
  29. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45(suppl 4):S49–S59S69-75
  30. Abraham PA, Macres MG. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol. 1991;2:927–936
  31. Buckner FS, Eschbach JW, Haley NR, Davidson RC, Adamson JW. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens. 1990;3:947–955
  32. Song JH, Park GH, Lee SY, Lee SW, Lee SW, Kim M-J. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol. 2005;16:237–246
  33. Song JH, Lee SW, Suh CK, Kim MJ. Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis. 2002;40:291–301
  34. Dolson GM, Ellis KJ, Bernardo MV, Prakash R, Adrogue HJ. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis. 1995;26:321–326
  35. van Kuijk WH, Mulder AW, Peels CH, Harff GA, Leunissen KM. Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis. Clin Nephrol. 1997;47:190–196
  36. Henrich WL, Hunt JM, Nixon JV. Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med. 1984;310:19–23
  37. Sherman RA, Bialy GB, Gazinski B, Bernholc AS, Eisinger RP. The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis. 1986;8:244–247
  38. Leunissen KM, van den Berg BW, van Hooff JP. Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis. Blood Purif. 1989;7:233–239
  39. Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant. 2008;24:973–981
  40. Maynard JC, Cruz C, Kleerekoper M, Levin NW. Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med. 1986;104:358–361
  41. van der Sande FM, Cheriex EC, van Kuijk WH, Leunissen KM. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis. 1998;32:125–131
  42. Kyriazis J, Katsipi I, Stylianou K, Jenakis N, Karida A, Daphnis E. Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nephron Clin Pract. 2007;106:c34–c42
  43. Kyriazis J, Stamatiadis D, Mamouna A. Intradialytic and interdialytic effects of treatment with 1.25 and 1.75 mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis. Am J Kidney Dis. 2000;35:1096–1103
  44. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol. 1998;18:535–541
  45. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–2439
  46. Mourad A, Khoshdel A, Carney S, et al. Haemodialysis-unresponsive blood pressure: cardiovascular mortality predictor?. Nephrology (Carlton). 2005;10:438–441
  47. Doumas MN, Douma SN, Petidis KM, Vogiatzis KV, Bassagiannis IC, Zamboulis CX. Different effects of losartan and moxonidine on endothelial function during sympathetic activation in essential hypertension. J Clin Hypertens. 2004;6:682–689
  48. Saijonmaa O, Metsarinne K, Fyhrquist F. Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture. Blood Press. 1997;6:24–28
  49. Prasad VS, Palaniswamy C, Frishman WH. Endothelin as a clinical target in the treatment of systemic hypertension. Cardiol Rev. 2009;17:181–191
  50. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis. 1997;29:383–391
  51. Suri RS, Nesrallah GE, Mainra R, et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol. 2006;1:33–42
  52. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005;67:1500–1508
  53. Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol. 2005;289:F679–F684

 Originally published online as doi:10.1053/j.ajkd.2009.08.013 on October 23, 2009.

PII: S0272-6386(09)01145-7

doi: 10.1053/j.ajkd.2009.08.013

American Journal of Kidney Diseases
Volume 55, Issue 3 , Pages 580-589 , March 2010

Article Tools

* Image Usage & Resolution